AU2002213114A1 - Compositions and methods for reducing gnrh-induced bone loss - Google Patents

Compositions and methods for reducing gnrh-induced bone loss

Info

Publication number
AU2002213114A1
AU2002213114A1 AU2002213114A AU1311402A AU2002213114A1 AU 2002213114 A1 AU2002213114 A1 AU 2002213114A1 AU 2002213114 A AU2002213114 A AU 2002213114A AU 1311402 A AU1311402 A AU 1311402A AU 2002213114 A1 AU2002213114 A1 AU 2002213114A1
Authority
AU
Australia
Prior art keywords
gnrh
compositions
reducing
methods
bone loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213114A
Inventor
Steven C. Quay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atossa Healthcare Inc
Original Assignee
Atossa Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atossa Healthcare Inc filed Critical Atossa Healthcare Inc
Publication of AU2002213114A1 publication Critical patent/AU2002213114A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU2002213114A 2000-10-10 2001-10-10 Compositions and methods for reducing gnrh-induced bone loss Abandoned AU2002213114A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68645200A 2000-10-10 2000-10-10
US09686452 2000-10-10
PCT/US2001/031786 WO2002030451A1 (en) 2000-10-10 2001-10-10 Compositions and methods for reducing gnrh-induced bone loss

Publications (1)

Publication Number Publication Date
AU2002213114A1 true AU2002213114A1 (en) 2002-04-22

Family

ID=24756348

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213114A Abandoned AU2002213114A1 (en) 2000-10-10 2001-10-10 Compositions and methods for reducing gnrh-induced bone loss

Country Status (2)

Country Link
AU (1) AU2002213114A1 (en)
WO (1) WO2002030451A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2010113968A (en) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) APPLICATION OF A PEPTIDE AS A THERAPEUTIC
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
CN114088855B (en) * 2021-11-16 2022-10-28 河南农业大学 Feces biomarker for early diagnosis of tibial cartilage dysplasia of broiler chicken and application thereof

Also Published As

Publication number Publication date
WO2002030451A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2002213114A1 (en) Compositions and methods for reducing gnrh-induced bone loss
AU2001249967A1 (en) Composition and methods for tissue preservation
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2778801A (en) Antisense compositions and methods
AU2001245660A1 (en) Embolic compositions
AU2002226223A1 (en) Syntactic deformable foam compositions and methods for making
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001253065A1 (en) Compositions and methods for treating hair loss using oximyl- and hydroxylamino-prostaglandins
AU2001266926A1 (en) Hemostatic compositions, devices and methods
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2002331890A1 (en) Compositions and methods involved in bone growth
AU2002345353A1 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001233932A1 (en) Method and composition
IL158764A0 (en) Methods and compositions for making emamectin
AU2002353078A1 (en) Tissue graft compositions and methods for producing same
AU2002245510A1 (en) Method and composition for embalming
AU2001261513A1 (en) Composition and method for increasing testosterone levels
AU2002239775A1 (en) Chemical-library composition and method
AU2002365136A1 (en) Compositions and methods for controlled release
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU5243899A (en) Methods and compositions for using moclobemide